Jayakanth Kankanala
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
-
- Cancer therapeutics and mechanisms 6
- Biochemical and Molecular Research 5
-
- HIV/AIDS drug development and treatment 12
- Co-authors
- Zhengqiang Wang (23 shared papers)Stefan G. Sarafianos (11 shared papers)Daniel J. Wilson (8 shared papers)Karen A. Kirby (9 shared papers)Sanjeev Kumar V. Vernekar (5 shared papers)Michael A. Parniak (6 shared papers)Mary C. Casey (8 shared papers)Andrew D. Huber (7 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)European Journal of Medicinal Chemistry (6 papers)British Journal of Pharmacology (2 papers)Acta Pharmaceutica Sinica B (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Jayakanth Kankanala
30 papers receiving 864 citations
Peers
Comparison fields: 5 of 63
- Virology 243
- Infectious Diseases 301
- Organic Chemistry 301
- Toxicology 27
- Hepatology 53
Countries citing papers authored by Jayakanth Kankanala
This map shows the geographic impact of Jayakanth Kankanala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayakanth Kankanala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayakanth Kankanala more than expected).
Fields of papers citing papers by Jayakanth Kankanala
This network shows the impact of papers produced by Jayakanth Kankanala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayakanth Kankanala. The network helps show where Jayakanth Kankanala may publish in the future.
Co-authors
The 25 scholars most cited alongside Jayakanth Kankanala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 123 | |
| 2 | 2015 | 76 | |
| 3 | 2016 | 58 | |
| 4 | 2016 | 52 | |
| 5 | 2013 | 48 | |
| 6 | 2017 | 37 | |
| 7 | 2017 | 37 | |
| 8 | 2016 | 36 | |
| 9 | 2011 | 30 | |
| 10 | 2016 | 30 | |
| 11 | 2018 | 28 | |
| 12 | 2013 | 27 | |
| 13 | 2020 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2016 | 23 | |
| 16 | 2018 | 23 | |
| 17 | 2019 | 21 | |
| 18 | 2020 | 19 | |
| 19 | 2018 | 18 | |
| 20 | 2015 | 18 |
About Jayakanth Kankanala
Jayakanth Kankanala is a scholar working on Molecular Biology, Infectious Diseases, Virology, Epidemiology and Organic Chemistry, having authored 30 papers that have together received 868 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers), Cancer therapeutics and mechanisms (6 papers), Biochemical and Molecular Research (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Virology (243 citations), Infectious Diseases (301 citations), Organic Chemistry (301 citations), Toxicology (27 citations) and Hepatology (53 citations). Jayakanth Kankanala has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Zhengqiang Wang, Stefan G. Sarafianos, Daniel J. Wilson, Karen A. Kirby, Sanjeev Kumar V. Vernekar, Michael A. Parniak, Mary C. Casey, Andrew D. Huber, Robert J. Geraghty and Jiashu Xie. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, British Journal of Pharmacology, Acta Pharmaceutica Sinica B and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.